WO2010002552A1 - Process for concentrating and processing fluid samples - Google Patents
Process for concentrating and processing fluid samples Download PDFInfo
- Publication number
- WO2010002552A1 WO2010002552A1 PCT/US2009/046755 US2009046755W WO2010002552A1 WO 2010002552 A1 WO2010002552 A1 WO 2010002552A1 US 2009046755 W US2009046755 W US 2009046755W WO 2010002552 A1 WO2010002552 A1 WO 2010002552A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- recited
- target
- microbiological
- membrane
- lysate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
Definitions
- the invention pertains to a process for concentrating fluid samples to obtain biological nucleic acid target materials for analysis.
- Detection and control of microorganisms are important in many fields including health care, environmental regulation, bio-warfare, pathogen identification, food and drug testing, and in a variety of industrial systems.
- presence of undesirable microorganisms decreases the efficiency of operating equipment and ultimately increases the cost of associated goods or services.
- microorganisms multiply rapidly, presence of microbial activity also causes health risks to the public. There is an increasing concern with pathogenic organisms infecting water and process system and creating increased human, animal, and environmental health risk.
- cooling towers for example, water borne pathogenic microorganisms such as Legionella sp. may be present. If not properly treated with preferred biocides, aerosolized particles containing the microorganisms can create extreme health concerns from inhalation of the aerosolized microorganisms leading to disease such as Pontiac fever or the sometimes fatal Legionnaire 's disease caused by Legionella pneumophila. Detection of this microorganism is difficult in the case of open recirculation water systems such as cooling towers because low concentrations represent serious health risk, and large water volumes must be concentrated into smaller sample volumes in order to perform the desired analytical test and obtain accurate and reproducible results.
- the invention pertains to a method of treating a liquid sample having non-target microbiological particles, inorganic particles, and microbiological target species such as cells or viruses therein.
- the microbiological target species comprise target materials enveloped therein.
- the sample is passed through a prefilter medium to allow the target species to pass there through as filtrate. Some of the non-target biological particles and inorganic particles are retained on the pref ⁇ lter medium.
- the filtrate from the prefiltering step is contacted by a main filtration medium that is adapted to retain the biological target species thereon as retentate along with other non-target microorganisms.
- the retentate from the main filtration step is lysed to form a lysate containing the target material.
- the cell lysate passes through the main filtration medium and is further contacted by a post filtration medium to retain unlysed cells thereon while allowing passage of the target material therethrough as filtrate.
- the main filtration medium may be pretreated with a retention enhancement agent or agents to improve the retainment of the microbiological target species on the main filter medium.
- the main filtration medium may be treated with a member or members chosen from the group consisting of surfactants, chelate reagents, salts, and organic solvents. These treatment agents both maintain the integrity of the microbiological target species therein (e.g., cells and viruses) during the main filter capture step and prevent the microbiological target species from irreversibly adhering to the filter material. This assures that a representative sample can be lysed and produce a testing sample that accurately represents the starting material.
- the present invention relates to a sample collection and processing method including filtration and lysis steps.
- the method features membranes to filter high volumes of liquid quickly and collect target components in a liquid by a two-step method including a prefiltration step and a main filtration step.
- the process deploys a post- concentration mechanical or non-mechanical means to release the desired enveloped target material into the solution.
- the sample solution is then stabilized for downstream analysis.
- microbiological target species may comprise cellular organisms such as bacteria, algae, fungi, prokaryotes, etc. or viruses.
- the target material nucleic acid such as DNA or RNA
- nucleic acid is located inside the cell.
- the nucleic acid is located with a protein coat.
- Lysing is then a rupturing of the cells or protein coat to release the desired target nucleic acid material.
- the method may be used to measure microbiological content. Exemplary microorganisms such as bacteria, virus, algae, fungi, and prokaryotes may be measured in accordance with the method.
- the biological content to be processed in accordance with the methods may be derived from any water or process system such as process water, drinking water, municipal water, cooling water, personal care product manufacturing, in-process pharmaceutical, or food and beverage processes.
- membranes are employed in a prefiltration system to remove any inorganic particles and large biological particles.
- the prefiltration membrane or membranes do not retain the target species.
- This membrane can be any membrane of a variety of a variety of different materials and pore sizes, but preferably one with a controlled pore size that separates at a fixed dimension.
- Non-limiting examples of prefiltration membrane materials are nylon, stainless steel, cellulose esters, PTFE, glass fibers, polypropylene, polyvinylchloride, hydrophilic acrylic copolymers, polyether sulfones, polycarbonates, and polyesters.
- Membranes of different pore sizes can be applied depending on the desired end use application.
- Non- limiting examples of membrane pore size for the prefiltration system are from about 1 ⁇ m, to about 100 ⁇ m, more preferably from about 1 ⁇ m to about 50 ⁇ m, but any membrane that can be used as a prefilter using the instant methods should perform a similar function and should have a well-defined pore size, e.g., a mesh structure to assure that the loss of the target materials on the prefilter membrane is minimized.
- plural prefiltration membranes can be provided and are arranged in an upstream to downstream flow orientation.
- the upstream membrane or membranes will have a higher porosity than the downstream membranes.
- the prefilter serves two purposes. First, it captures larger particles, fungi, algae, and biofilm that, if allowed to transfer to the main membrane, could agglomerate with organics and small particles and inhibit flow. This results in either long filtration times or the inability to filter the total volume required to create a representative sample. Second, the prefilter traps larger life forms like amoeba that are known to harbor Legionella. In one embodiment, the test is for planktonic Legionella, and the amoeba would expel very large numbers of Legionella if lysed.
- a pair of nylon prefiltration membranes may be used with the upstream membrane in the pair having a pore size of about 20 ⁇ m with the downstream membrane having pores on the order of about 10-11 ⁇ m.
- the main filtration medium comprises a membrane designed to retain the desired target species.
- This species may comprise cellular materials or viruses.
- This membrane can be any member of a different material or pore size.
- Nonlimiting examples of membranes that may be used as the main filtration medium are nylon, stainless steel, cellulose esters, PTFE, glass fiber, polypropylene, polyvinyl chloride, hydrophilic acrylic copolymer, polyethersulfone, polycarbonate, and polyester.
- the main filtration membrane functions to retain the target component thereon as retentate.
- the lysate may be capable of passing through the main filtration medium for subsequent downstream assay or other process.
- the lysate may be prevented from passing through the main membrane by placing a barrier on the bottom of the membrane.
- the lysing action may be performed by shaking, and the lysed product may be extracted through a post concentration membrane (e.g., PES 0.2 ⁇ m).
- the lysate in one embodiment, could be recirculated in a closed system on multiple passes through the main filter for a predetermined recycling time. Then, the lysate continuing the target material nucleic acid could be removed from the recirculation system for subsequent analysis.
- glass fiber main filtration members may be used and those having pore sizes of between about 10 nm to about 3.0 ⁇ m may be mentioned as exemplary. More preferred are those main filter membranes having pore sizes on the order of between about 0.7 ⁇ m to about 2.7 ⁇ m.
- the main membrane pore size requires consideration of two characteristics. First, it must retain the desired target species thereon while not allowing them to stick to the membrane and be lysed to release the enveloped target material during the concentration step. In that case, the target materials such as nucleic acids would be released during the concentration step and be passed with the filtrate. It is desired to keep the target species (e.g., cellular and viral) intact during the concentration step so that they can be lysed during the lysing step. Second, the membrane should have sufficient porosity to assure that a large volume of sample can be filtered in a time that is practical for efficient sample testing.
- the main filter membrane in accordance with one aspect of the invention, may be treated with chemical or fluidic retention enhancement agents such as surfactants, acids, bases, chelating reagents, salts, organic solvents, etc., to enhance target species retention on the main filtration medium while allowing practical sample flow through the membrane.
- chemical or fluidic retention enhancement agents such as surfactants, acids, bases, chelating reagents, salts, organic solvents, etc.
- Suitable surfactants include zwitterionic surfactants, anionic surfactants, cationic surfactants, and nonionic surfactants.
- the filtration system including both the prefiltration and main filtration media can, in one embodiment, filter quantitative broad volumes of liquid samples with high flow rates.
- an exemplary sample volume could be 10 liters or more.
- the sample could be filtered by an integral filtration system with gravity or pressure assistance. Filtration by pressure includes negative pressure and positive pressure.
- pumps could be used to make negative pressure such as vacuum air pumps, diaphragm liquid pumps, peristatic pumps, etc.
- the target species such as microbiological contents retained by the main filtration medium, could be used for different applications like physical, chemical, and biological characterization, etc.
- the main membrane containing the desired target cells is exposed to a lysing buffer designed to produce a small volume of stabilized lysate containing nucleic acid and proteins, etc. for downstream detection such as Polymerase Chain Reaction (PCR), real time PCR, reverse transcription realtime PCR, etc. or other molecular test methods.
- PCR Polymerase Chain Reaction
- real time PCR real time PCR
- reverse transcription realtime PCR etc.
- Good integrity of the nucleic acid released from the target species can be obtained if the appropriate lysing material is used and can be stabilized in the lysate for 72 hours or more at temperatures of from about 4°C-43°C.
- Target species lysing occurs by cell or protein envelope rupture and can be classified as including non-mechanical or mechanical methods.
- Non- mechanical methods include chemical methods, thermal methods, enzymatic methods, etc.
- Mechanical methods include ultrasonic disruption using a homogenizer; pressing using, for example, a French press, etc., decompression, pulverization, etc.
- a non-limiting example is a chemical lysis method that would include any suitable chemical that can disrupt cell or protein envelope barriers.
- Detergents are a non- limiting example of chemicals that are commonly used to disrupt a lipid double layer membrane to release cell contents and lyse membrane protein, and non-limiting examples of suitable lysing chemicals are lithium dodecyl sulfate, CHAPS, Tween-20E, NP40, CTAB, PVPP, Triton X series detergents, sodium cholate, and sodium deoxycholate, guanidinium hydrochloride, or caustic. Chaotropic agents like guanidiunium salts can also act as lysing agents in this system.
- lysing efficiency of detergents and alternate lysing agents is dependent on the cell types and specific applications.
- Enzymes such as lysozymes, mutanolysin, labiase, lysostaphin, lyticase, proteinase K, endolysin and achromopeptidases may be included as lysing reagents or additives to enhance lysing.
- Organic solvents, such as DMSO, DMF could be also included as lysing reagents or additives to enhance lysing.
- a host of bioscience suppliers offer a wide collection of lysing buffers suitable for cell lysis application.
- a variety of physical methods such as shaking, heating, cutting and homogenizing, etc., could be employed in the process to enhance the lysing efficiency. Indeed in one embodiment a cutting action may be employed in which the cells may be ruptured and the main membrane itself will be cut. Based on the complexity of the application and the nature of the target species types, single or combinations of chemical lysis methods could be used in combination with mechanical methods.
- an additional membrane or membranes could be added to process the cell lysate for downstream application.
- the membrane could be any membrane of different materials whose pore size is in the range of 0.22 ⁇ m to 0.45 ⁇ m for bacterial, yeast, fungi, or protogen sampling. (Virus sampling will require smaller pore sizes).
- Non-limited examples of these "post" f ⁇ ltrations membrane materials are PVDF, PES, polycarbonate, nylon, etc. This membrane acts primarily to remove large materials and/or unlysed cells from the sample to enhance long term stability of the lysate at the conditions noted above.
- the filtrate from step 2 was concentrated by surfactant treated glass fiber 2.7 ⁇ m (Millipore APFD04700) to retain the target species contents.
- the main membranes from step 3 were added with 3 ml lysis buffer and lyzed for 5 minutes with the shaking speed of 100 round/minute.
- the lysis buffer solution comprises lithium lauryl sulfate, DMSO, and ethoxylated nonyl phenol.
- the lysates were filtered through PES 0.22 ⁇ m ⁇ 0.45 ⁇ m membranes for downstream analysis.
- the controls are the same amount of target content detection by lysis without concentration.
- ⁇ Vendor membranes that are not specifically identified are available from GE Osmonics.
- Optimal shaking speeds and lysis time were determined. Based on this data, an optimal shaking speed was determined at 2x or at 100 R.P.M. with a total lysis solution contact time of 5 minutes appearing optimal.
- RNA assay was made to determine the amount of Legionella pneumophila in the lysate.
- Selected main filter membrane and lysis buffer performance were assessed at different concentrations of the target, Legionella pneumophila cells. No treatment indicates a lack of pretreatment of the filter. STM treatment indicates that the filter was pretreated with the lysis buffering solution.
- the repeatability of a device integrating the selected membrane and lysis buffer tested 5 log levels of Legionella pneumophila cells.
- testing was undertaken to determine the effect of an additional filtering step, after the main filtering. After prefiltering and main filtering with lysing, the lysate was passed through a PES 0.22 ⁇ m filter to retain unlysed cells and pass lysate as filtrate.
- the processes herein described takes less than 15 minutes from the time in which the sample collection is taken to obtain a stabilized biomaterial sample ready for transport to downstream testing.
- stable extracts from the biomaterials are provided that retain stability for up to 72 hours at temperatures up to about 43°C.
- the prefiltration and main filtration steps are dead end filtering steps.
- pretreatment of the main filter medium via surfactants or other retention enhancement agents may be employed.
- Surfactants may be present in concentration ranges of about 0.5% to about 5%.
- chelating reagents when utilized to pretreat the main filter membrane, these may be present in concentration of about 0.1 mM to 100 mM. These chelating reagents may comprise for example EDTA and EGTA etc.
- salts may be used to pretreat the main filtration membrane, and these may be present in an amount of about 1-8 mM solutions, and in those cases in which organic solvents may be utilized for pretreatment of the main filtration medium, these may be present in an amount of about 1-10%.
- the samples may be incubated at temperatures of about 30 0 C to 100 0 C.
- electrical fields may be employed to help release the intracellular material.
- Shaking, inverting, or vibration via impellers and the like may be utilized again as an aid or aids in the lysing operations.
- Shaking speeds of from about 10-350 RPM may be employed in those instances in which shaking may be found useful to enhance the lysing operation and the lysing operation may generally proceed for anywhere from about between 1 minute to 3 hours.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09774004A EP2303435A1 (en) | 2008-06-30 | 2009-06-09 | Process for concentrating and processing fluid samples |
BRPI0910202A BRPI0910202A2 (en) | 2008-06-30 | 2009-06-09 | method for treating a liquid sample |
CN200980126140.0A CN102076400B (en) | 2008-06-30 | 2009-06-09 | Process for concentrating and processing fluid samples |
CA2728331A CA2728331A1 (en) | 2008-06-30 | 2009-06-09 | Process for concentrating and processing fluid samples |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/215,768 | 2008-06-30 | ||
US12/215,768 US8158405B2 (en) | 2008-06-30 | 2008-06-30 | Process for concentrating and processing fluid samples |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010002552A1 true WO2010002552A1 (en) | 2010-01-07 |
Family
ID=41152181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/046755 WO2010002552A1 (en) | 2008-06-30 | 2009-06-09 | Process for concentrating and processing fluid samples |
Country Status (9)
Country | Link |
---|---|
US (1) | US8158405B2 (en) |
EP (1) | EP2303435A1 (en) |
CN (1) | CN102076400B (en) |
AR (1) | AR072282A1 (en) |
BR (1) | BRPI0910202A2 (en) |
CA (1) | CA2728331A1 (en) |
CL (1) | CL2009001488A1 (en) |
TW (1) | TW201009071A (en) |
WO (1) | WO2010002552A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8790916B2 (en) | 2009-05-14 | 2014-07-29 | Genestream, Inc. | Microfluidic method and system for isolating particles from biological fluid |
DE102011105525B4 (en) * | 2011-06-24 | 2015-03-26 | Sartorius Stedim Biotech Gmbh | Process for separating biopolymer aggregates and viruses from a fluid |
GB201617713D0 (en) | 2016-10-19 | 2016-11-30 | Q-Linea Ab | Method for recovering microbial cells |
CN109868205A (en) * | 2017-12-05 | 2019-06-11 | 台达电子国际(新加坡)私人有限公司 | Biological sample processing unit and its biological sample processing method |
CN109306370A (en) * | 2018-09-26 | 2019-02-05 | 浙江海洋大学 | Nano material coerces the detection method of lower Copepods DNA damage |
CN112305221A (en) * | 2020-10-29 | 2021-02-02 | 海卫特(广州)医疗科技有限公司 | Canine parvovirus detection kit and preparation method thereof |
CN113136412A (en) * | 2021-04-22 | 2021-07-20 | 浙江珂瑞康生物医疗科技有限公司 | Biological load determination treatment liquid for biomedical material containing soluble protein |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2693474A1 (en) * | 1992-07-09 | 1994-01-14 | Garin Daniel | Water contaminating microorganism sepn. and concn. to detect entero viruses - by on site sampling and tangential ultrafiltration for virus recovery |
US20050115903A1 (en) * | 2002-04-09 | 2005-06-02 | Genesystems | Method and apparatus for extracting nucleic acids from a complex mixture |
US20060263773A1 (en) * | 2004-11-30 | 2006-11-23 | Kojiro Tanaka | Measuring kit, measuring method and measuring apparatus of microorganism in liquid sample |
WO2006129038A2 (en) * | 2005-06-03 | 2006-12-07 | Veolia Eau - Compagnie Generale Des Eaux | Method for quantifying living coliform microorganisms in a water sample |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1544508A (en) | 1975-04-04 | 1979-04-19 | Millipore Corp | Filtration apparatus |
US4137169A (en) | 1976-11-12 | 1979-01-30 | Filter Tech, Inc. | Liquid filtration system |
US4358535A (en) | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology |
US4518402A (en) | 1981-11-10 | 1985-05-21 | Dargel Robert L | Reuseable air filter system |
US4976876A (en) | 1988-03-14 | 1990-12-11 | The Kendall Company | Point-of-use membrane filtration system |
NL8900725A (en) | 1989-03-23 | 1990-10-16 | Az Univ Amsterdam | METHOD AND COMBINATION OF AGENTS FOR INSULATING NUCLEIC ACID. |
US5096474A (en) | 1989-12-13 | 1992-03-17 | Air Systems International, Inc. | Negative pressure filtration device |
IE914558A1 (en) | 1991-02-28 | 1992-09-09 | Abbott Lab | Isolation of proteins by ultrafiltration |
US5155018A (en) | 1991-07-10 | 1992-10-13 | Hahnemann University | Process and kit for isolating and purifying RNA from biological sources |
AU664050B2 (en) | 1991-12-18 | 1995-11-02 | Becton Dickinson & Company | Process for lysing mycobacteria |
WO1993017341A1 (en) * | 1992-02-24 | 1993-09-02 | Genelabs Technologies, Inc. | Htlv-i/htlv-ii assay and method |
GB9314249D0 (en) * | 1993-07-09 | 1993-08-18 | Proofname Ltd | Purification method and apparatus |
WO1995006652A1 (en) | 1993-08-30 | 1995-03-09 | Promega Corporation | Nucleic acid purification compositions and methods |
US5456835A (en) | 1993-11-08 | 1995-10-10 | Hemasure, Inc. | Device and process for removing free hemoglobin from blood |
US5458782A (en) | 1994-01-07 | 1995-10-17 | Cuno Incorporated | Hydrolytically stable nylon membrane |
DE4421871C2 (en) | 1994-06-23 | 1997-06-19 | Seitz Filter Werke | Multi-layer microfiltration membrane with integrated pre-filter layer and process for its production |
US5783686A (en) | 1995-09-15 | 1998-07-21 | Beckman Instruments, Inc. | Method for purifying nucleic acids from heterogenous mixtures |
US5669946A (en) | 1996-01-26 | 1997-09-23 | Blair, Jr.; Earl W. | Air particulate filtration device |
US5643425A (en) * | 1996-03-14 | 1997-07-01 | Hoshizaki Denki Kabushiki Kaisha | Saturated brine tank in apparatus for production of electrolyzed water |
NL1004489C2 (en) | 1996-11-11 | 1998-05-14 | X Flow Bv | Filtration membrane module. |
US20070185033A1 (en) * | 1996-12-11 | 2007-08-09 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
EP0860444A1 (en) | 1997-02-24 | 1998-08-26 | Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis (CLB) | Method for removing viruses from a protein solution |
DE19709186C2 (en) | 1997-03-06 | 1999-10-14 | Medigene Ag | Filtration process for the separation of viruses |
ATE329012T1 (en) | 1997-04-08 | 2006-06-15 | Pall Corp | METHOD FOR OBTAINING RARE CELLS FROM BLOOD PRODUCTS |
US6015493A (en) | 1997-07-14 | 2000-01-18 | Teleparts International, Inc. | Multiple filtration bypass method and apparatus for reducing particles in liquid distribution systems |
US6508936B1 (en) | 1997-10-01 | 2003-01-21 | Saline Water Conversion Corporation | Process for desalination of saline water, especially water, having increased product yield and quality |
US5972613A (en) | 1997-12-09 | 1999-10-26 | The Perkin-Elmer Corporation | Methods of nucleic acid isolation |
EP0969090A1 (en) | 1998-05-27 | 2000-01-05 | QIAGEN GmbH | Rapid and simple process for isolation of circular nucleic acids |
US6958392B2 (en) | 1998-10-09 | 2005-10-25 | Whatman, Inc. | Methods for the isolation of nucleic acids and for quantitative DNA extraction and detection for leukocyte evaluation in blood products |
CA2253697A1 (en) | 1998-11-09 | 2000-05-09 | Fantom Technologies Inc. | Water purifier |
WO2000027510A1 (en) | 1998-11-10 | 2000-05-18 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for filtration with membrane |
US6405875B1 (en) | 1998-12-18 | 2002-06-18 | Corning Incorporated | Water filtration device and method |
JP3990505B2 (en) | 1999-02-02 | 2007-10-17 | 富士フイルム株式会社 | Blood component analysis method |
US6544424B1 (en) | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
NL1016486C2 (en) | 2000-10-26 | 2002-05-01 | Prime Water Systems Gmbh | Filter device with a cylindrical pre-filter around a filtration membrane module. |
DE10061140A1 (en) * | 2000-12-08 | 2002-06-13 | Merck Patent Gmbh | Methods and means for determining total hardness |
CN1308130A (en) * | 2000-12-26 | 2001-08-15 | 李永武 | Method of extracting nucleic and from microbe cell |
GB0100513D0 (en) | 2001-01-09 | 2001-02-21 | Smithkline Beecham Plc | Process |
ATE309344T1 (en) | 2001-01-19 | 2005-11-15 | Mueller Drm Ag | METHOD FOR PREPARING BIOMASS FOR PRODUCING CELL LYSATE CONTAINING PLASMID DNA |
US6551642B2 (en) | 2001-03-08 | 2003-04-22 | Cocotech, Inc. | Process for removing oil from foodstuffs using a membrane filter |
DK200100286U4 (en) | 2001-10-24 | 2003-02-14 | Bin X As | Filtration system with hydrophilic capillary membranes |
AUPR914701A0 (en) | 2001-11-27 | 2001-12-20 | Coffey, John I | Method for controlling legionella in cooling towers |
US20030201229A1 (en) | 2002-02-04 | 2003-10-30 | Martin Siwak | Process for prefiltration of a protein solution |
JP2003289899A (en) * | 2002-04-03 | 2003-10-14 | Aquas Corp | Method for examining legionella bacterium in specimen |
AU2003299514A1 (en) | 2003-05-19 | 2004-12-13 | Millipore Corporation | Process for prefiltration of a protein solution |
CN1239471C (en) * | 2003-10-20 | 2006-02-01 | 林坤华 | Continuous amino acid producing process with fish processing waste water |
SE0400501D0 (en) | 2004-02-27 | 2004-02-27 | Amersham Biosciences Ab | Antibody purification |
CA2559943A1 (en) * | 2004-03-15 | 2005-10-06 | Purdue Research Foundation | Cell concentration and pathogen recovery |
ES2245875B1 (en) * | 2004-03-26 | 2006-11-16 | Joaquin Espuelas Peñalva | MANUFACTURING AND FILTER PROCESS OF NON-WOVEN FABRIC AND / OR FILTERING INJECTED SHEETS OR STRUCTURES OBTAINED BY SUCH PROCESS FOR FILTRATION AND ELIMINATION OF THE PNEUMOFILA LEGIONELLA. |
JP2007111572A (en) | 2004-05-31 | 2007-05-10 | Entegris Inc | Functionalized membrane, and filtration material and filter element using the same |
US7220549B2 (en) | 2004-12-30 | 2007-05-22 | Helicos Biosciences Corporation | Stabilizing a nucleic acid for nucleic acid sequencing |
EP1710011A1 (en) | 2005-04-07 | 2006-10-11 | Gambro Lundia AB | Filtration membrane |
WO2007004263A1 (en) | 2005-06-30 | 2007-01-11 | Ngk Insulators, Ltd. | Filter |
JP4874008B2 (en) * | 2005-07-01 | 2012-02-08 | 水ing株式会社 | Method and apparatus for detecting bacteria |
CA2628271A1 (en) * | 2005-11-02 | 2007-05-10 | Sure International Ventures B.V. | Compositions and methods for cell killing |
EP1984102A4 (en) | 2005-12-09 | 2010-05-19 | Siemens Water Tech Corp | Reduced backwash volume process |
US8137626B2 (en) * | 2006-05-19 | 2012-03-20 | California Institute Of Technology | Fluorescence detector, filter device and related methods |
-
2008
- 2008-06-30 US US12/215,768 patent/US8158405B2/en active Active
-
2009
- 2009-06-09 BR BRPI0910202A patent/BRPI0910202A2/en not_active IP Right Cessation
- 2009-06-09 EP EP09774004A patent/EP2303435A1/en not_active Ceased
- 2009-06-09 CA CA2728331A patent/CA2728331A1/en not_active Abandoned
- 2009-06-09 WO PCT/US2009/046755 patent/WO2010002552A1/en active Application Filing
- 2009-06-09 CN CN200980126140.0A patent/CN102076400B/en not_active Expired - Fee Related
- 2009-06-18 TW TW098120488A patent/TW201009071A/en unknown
- 2009-06-22 AR ARP090102286A patent/AR072282A1/en not_active Application Discontinuation
- 2009-06-26 CL CL2009001488A patent/CL2009001488A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2693474A1 (en) * | 1992-07-09 | 1994-01-14 | Garin Daniel | Water contaminating microorganism sepn. and concn. to detect entero viruses - by on site sampling and tangential ultrafiltration for virus recovery |
US20050115903A1 (en) * | 2002-04-09 | 2005-06-02 | Genesystems | Method and apparatus for extracting nucleic acids from a complex mixture |
US20060263773A1 (en) * | 2004-11-30 | 2006-11-23 | Kojiro Tanaka | Measuring kit, measuring method and measuring apparatus of microorganism in liquid sample |
WO2006129038A2 (en) * | 2005-06-03 | 2006-12-07 | Veolia Eau - Compagnie Generale Des Eaux | Method for quantifying living coliform microorganisms in a water sample |
Non-Patent Citations (1)
Title |
---|
YARADOU DIARAF FARBA ET AL: "Integrated real-time PCR for detection and monitoring of Legionella pneumophila in water systems.", APPLIED AND ENVIRONMENTAL MICROBIOLOGY MAR 2007, vol. 73, no. 5, March 2007 (2007-03-01), pages 1452 - 1456, XP002551859, ISSN: 0099-2240 * |
Also Published As
Publication number | Publication date |
---|---|
US20090326211A1 (en) | 2009-12-31 |
CN102076400B (en) | 2015-07-22 |
CA2728331A1 (en) | 2010-01-07 |
CN102076400A (en) | 2011-05-25 |
TW201009071A (en) | 2010-03-01 |
EP2303435A1 (en) | 2011-04-06 |
CL2009001488A1 (en) | 2010-10-08 |
AR072282A1 (en) | 2010-08-18 |
US8158405B2 (en) | 2012-04-17 |
BRPI0910202A2 (en) | 2015-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8158405B2 (en) | Process for concentrating and processing fluid samples | |
Brehm-Stecher et al. | Sample preparation: the forgotten beginning | |
AU751324B2 (en) | Solid-phase nucleic acid isolation | |
JP5259579B2 (en) | Method for extracting deoxyribonucleic acid (DNA) from microorganisms that may be present in a blood sample | |
US7893251B2 (en) | Methods for selective isolation of nucleic acids from microbial cells present in samples containing higher eukaryotic cells and/or tissues | |
Li et al. | Rapid sample processing for detection of food-borne pathogens via cross-flow microfiltration | |
US20090111170A1 (en) | Nucleic acid processing methods, kits and devices | |
WO2003016552A2 (en) | Dna purification and recovery from high particulate and solids samples | |
KR20120115242A (en) | Selective lysis of cells | |
Barbosa et al. | DNA extraction: finding the most suitable method | |
KR20100017232A (en) | Compositions, methods, and devices for isolating biological materials | |
CN109207475A (en) | A kind of Rapid nucleic acid extracting method | |
Mueller et al. | Variables influencing extraction of nucleic acids from microbial plankton (viruses, bacteria, and protists) collected on nanoporous aluminum oxide filters | |
US20140158619A1 (en) | Filtering devices comprising clay minerals | |
EP2245157A1 (en) | Method for the extraction and purification of nucleic acids on a membrane | |
WO2014151177A1 (en) | Sample concentrator and method of use | |
EP2526198A1 (en) | Rapid pathogen detection techniques and apparatus | |
WO2000062023A1 (en) | Fta-coated media for use as a molecular diagnostic tool | |
US11891599B2 (en) | Recovery of nucleic acids from solid supports | |
Bridle et al. | Sample processing | |
Lee et al. | Chemical trends in sample preparation for nucleic acid amplification testing (NAAT): a Review | |
CN109706143A (en) | A kind of extracting method of peripheral blood high molecular weight genomic DNA | |
Kretzer et al. | Sample preparation–an essential prerequisite for high-quality bacteria detection | |
WO2017116695A1 (en) | Assembly and method for field filtration of water samples | |
CA2739728A1 (en) | Recovery and detection of microorganisms from mixed cellulose ester filtration supports by sequential treatment with methanol and acetone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980126140.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09774004 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2009774004 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009774004 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2728331 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9039/DELNP/2010 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: PI0910202 Country of ref document: BR Kind code of ref document: A2 Effective date: 20101229 |